BMCMI
NXTM

Bryn Mawr Capital Management Inc’s NxStage Medical Inc. NXTM Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-27,633
Closed -$395K – 593
2015
Q2 		$395K Buy
+27,633
New +$468K 0.06% 303

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Bryn Mawr Capital Management Inc's NXTM Position: Q3 2015 in Review

Bryn Mawr Capital Management Inc sold out of NxStage Medical Inc. (NXTM) in Q3 2015, closing a stake of 27,633 shares — an estimated $395K sold.

Bryn Mawr Capital Management Inc first reported a position in NXTM in Q2 2015 and held it in 1 quarter. The position peaked at $395K in Q2 2015. 127 funds tracked by Wall St. Rank hold NXTM as of Q3 2015.

  • Bryn Mawr Capital Management Inc reported no remaining NxStage Medical Inc. position as of Q3 2015 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 27,633 NxStage Medical Inc. shares in Q3 2015, an estimated $395K.
  • Bryn Mawr Capital Management Inc first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 1 quarter.
  • Bryn Mawr Capital Management Inc's NxStage Medical Inc. position peaked at $395K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q3 2015, filed 12 Nov 2015.